RPG Life Sciences share news, announcements and annual reports
NSE: RPGLIFEBSE: 532983Pharmaceuticals & BiotechnologySmall Cap
RPG Life Sciences Limited · Face value ₹8 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 2008
Last close ₹2,844.00up ₹7.90 (0.28%)BSE ₹2,847.20
Share price at the NSE close on 28 Oct 2026. Previous close ₹2,836.10.
28 Oct: open ₹2,854.00, high ₹2,862.60, low ₹2,800.00
52-week range of traded prices to 28 Oct 2026
₹1,733.00Low, 23 Mar 2026₹3,127.80High, 25 Sep 2026
- Next results date: the board meets on 29 Oct 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,704 Cr923rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 39.38
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 7.77
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.84%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 21.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 5,99740.5% delivered
RPG Life Sciences has 677 announcements on record, routine notices left out; 2 in the 30 days to 29 Oct 2026, the latest on 23 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.RPG Life Sciences quarterly results
Oct29Thu
The board meets on 29 Oct 2026 to consider financial results
Notice filed 22 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
RPG Life Sciences annual reports, presentations and earnings calls
The company's own documents, latest first.RPG Life Sciences financials, year by year
Annual reports17
- Annual report, year to Mar 20261 Jul 2026
- Annual report, year to Mar 202523 Jun 2025
- Annual report, year to Mar 202424 Jun 2024
- Annual report, year to Mar 202313 Jul 2023, a zip file
- Annual report, year to Mar 20227 Jul 2022, a zip file
12 earlier reports
- Annual report, year to Mar 20217 Aug 2021, a zip file
- Annual report, year to Mar 202028 Jul 2020, a zip file
- Annual report, year to Mar 20199 Jul 2019, a zip file
- Annual report, year to Mar 20183 Aug 2018, a zip file
- Annual report, year to Mar 201731 Jul 2017, a zip file
- Annual report, year to Mar 201615 Sep 2016, a zip file
- Annual report, year to Mar 20153 Jul 2015, a zip file
- Annual report, year to Mar 20141 Sep 2014, a zip file
- Annual report, year to Mar 201215 Oct 2013, a zip file
- Annual report, year to Mar 201326 Aug 2013, a zip file
- Annual report, year to Mar 201121 Jul 2011, a zip file
- Annual report, year to Mar 201018 Aug 2010, a zip file
Investor presentations31
- Investor Presentation2 Sep 2026
- Investor Presentation28 Jul 2026
- Investor Presentation25 May 2026
- Investor Presentation30 Apr 2026
- Intimations of Revised Investor presentation28 Jan 2026
26 earlier presentations
- Investor Presentation in respect to the Board Meeting held on January 27, 202627 Jan 2026
- Investor Presentation17 Oct 2025
- Investor Presentation25 Jul 2025
- Investor Presentation2 Jun 2025
- Investor Presentation29 Apr 2025
- We would like to inform you that the Results Earnings Call for audited Financial Results of the Company for the quarter and half year ended Mar 31, 2025 will be held on Tuesday, April 29, 2025 at 3.30 p.m. IST. Please find below the dial-in-details for the said call.Dial-in Details:Indian (Universal) and Mumbai +91 22 6280 1116 +91 22 7115 8017Location Toll Free NumberUS 18667462133UK 08081011573Singapore 8001012045Hong Kong 800964448Diamond Pass Link Link to register- https://tinyurl.com/f62v7vrw The investor presentation shall be shared with the Exchanges separately.You are requested to kindly take the same on record and disseminate appropriately.23 Apr 2025
- Investor Presentation28 Jan 2025
- Investor Presentation8 Nov 2024
- Investor Presentation27 Jul 2024
- Investor Presentation6 Jun 2024
- Investor Presentation1 May 2024
- Investor Presentation2 Feb 2024
- Please find enclosed herewith a copy of Investor Presentation with respect to UnauditedFinancial Results of the Company for the quarter and half year ended September 30, 2023.Kindly take the same on record19 Oct 2023
- Investor Presentation19 Oct 2023
- Investor Presentation29 Jul 2023
- Investor Presentation2 May 2023
- We wish to inform you that the Results Earnings Call for Audited Financial Results of the Company for the quarter and year ended March 31, 2023 will be held on Tuesday, May 2, 2023 at 3.30 p.m. IST. The dial-in details are enclosed herewith.The investor presentation shall be shared with the Exchanges separately.You are requested to kindly take the same on record and disseminate appropriately.25 Apr 2023
- Investor Presentation2 Feb 2023
- Investor Presentation18 Oct 2022
- In continuation to our Letter dated September 12, 2022, please find enclosed herewith the Investor's Presentation which will be made during RPG Annual Investor Conference 2022.Kindly take the same on record.13 Sep 2022
- Please find enclosed herewith a copy of Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter ended June 30, 2022. Kindly take the same on record.4 Aug 2022
- In continuation of our Letters dated April 25, 2022 and April 29, 2022, please find enclosed herewith Investor Presentation for the quarter and year ended March 31, 2022, for the Results Earnings call scheduled on Monday, May 2, 2022, at 3.30 p.m. IST. Dial-in details of which are reproduced below for ready reference.30 Apr 2022
- Investor Presentation29 Jan 2022
- Investor Presentation29 Oct 2021
- Investor Presentation26 Jun 2021
- Investor Presentation14 Jun 2018, a zip file
Earnings calls24
- Link of Recording4 Sep 2026
- Transcript of Earnings Call.8 May 2026
- Link of Recording30 Apr 2026
- Transcript of Earnings call held on 17th October 202524 Oct 2025
- Link of Recording and outcome of Earning call18 Oct 2025
19 earlier call documents
- Second document filed with: The Company has informed about the recording of Earnings Call.18 Oct 2025
- Transcript5 May 2025
- In continuation of our Letters dated April 23, 2025 and April 29, 2025, we would like to inform you that audio recording of the Results Earnings Call for the Audited Financial Results for the quarter and financial year ended on March 31, 2025, held today i.e. Tuesday, April 29, 2025, at 3.30 p.m. IST. has been made available on the Company s website at https://www.rpglifesciences.com/website/earningscall.php.29 Apr 2025
- Transcript12 Nov 2024
- Link of Recording8 Nov 2024
- Transcript21 Sep 2024
- Link of Recording18 Sep 2024
- In continuation of our Letters dated April 26, 2024, May 01, 2024 and May 02, 2024, we would like to inform you that transcript of the Results Earnings Call for the Audited Financial Results for the quarter and year ended March 31, 2024, held on Thursday, May 02, 2024, at 3.30 p.m. IST. has been made available on the Company s website.8 May 2024
- Link of Recording2 May 2024
- Transcript25 Oct 2023
- In continuation of our Letters dated October 13, 2023 and October 19, 2023, we would like to inform you that audio recording of the Results Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2023, held today i.e. Thursday, October 19, 2023, at 3.30 p.m. IST. has been made available on the Company s website.Kindly take the same on record and disseminate appropriately.19 Oct 2023
- In continuation of our Letters dated April 25, 2023 and May 2, 2023, we would like to inform you that transcript of the Results Earnings Call for the Audited Financial Results for the quarter and year ended March 31, 2023, held on Tuesday, May 2, 2023, at 3.30 p.m. IST. has been made available on the Company s website at: https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.8 May 2023
- N continuation of our Letters dated April 29, 2023 and May 02, 2023, we would like to inform you that audio recording of the Results Earnings Call for the Audited Financial Results for the year ended March 31, 2023, held today i.e. Tuesday, May 2, 2023, at 3.30 p.m. IST. has been made available on the Company s website at https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.2 May 2023
- In continuation of our Letters dated October 11, 2022, October 17, 2022 and October 18, 2022, we would like to inform you that transcript of the Results Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2022, held on Tuesday, October 18, 2022, at 3.30 p.m. IST. has been made available on the Company's website at: https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.21 Oct 2022
- In continuation of our Letters dated October 11, 2022 and October 17, 2022, we would like to inform you that audio recording of the Results Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2022, held today i.e. Tuesday, October 18, 2022, at 3.30 p.m. IST. has been made available on the Company's website at https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.18 Oct 2022
- In continuation of our Letters dated April 25, 2022, April 29, 2022, April 30, 2022 and May 2, 2022, we would like to inform you that transcript of the Results Earnings Call for the Audited Financial Results for the quarter and year ended March 31, 2022, held on Monday, May 2, 2022, at 3.30 p.m. IST. has been made available on the Company's website at: https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.5 May 2022
- In continuation of our Letters dated April 25, 2022, April 29, 2022 and April 30, 2022, we would like to inform you that audio recording of the Results Earnings Call for the Audited Financial Results for the year ended March 31, 2022, held today i.e. Monday, May 2, 2022, at 3.30 p.m. IST. has been made available on the Company's website at https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.2 May 2022
- Transcript8 Nov 2021
- Link of Recording1 Nov 2021
RPG Life Sciences share news and announcements
Newest first. Page 1 of 14.
Oct 2026
22 Oct · Board meeting
Sep 2026
26 Sep
24 Sep · General Updates
23 Sep · Legal
The exchange asked on 23 Sep 2026
17 Sep · Analysts
3 Sep · Analysts
2 Sep · Analysts
2 Sep · Business
2 Sep · General Updates
1 Sep · General Updates
Aug 2026
25 Aug · Analysts
15 Aug · Management
15 Aug · Management
15 Aug · Updates
Jul 2026
31 Jul · Management
29 Jul · Business
29 Jul · General Updates
29 Jul · General Updates
28 Jul · Business
28 Jul · Results
27 Jul · Management
27 Jul · Management
27 Jul · Management
23 Jul · Meeting
23 Jul · Meeting
21 Jul · Board meeting
13 Jul · Business
1 Jul · Meeting
Jun 2026
22 Jun · Corporate action
12 Jun · Legal
The exchange asked on 11 Jun 2026
9 Jun · General Updates
9 Jun · General Updates
May 2026
22 May · Analysts
Apr 2026
29 Apr · Business
29 Apr · Results
29 Apr · Results
23 Apr · Analysts
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 17 Aug 2026Board or managers changeddown 1.47%−1.3 pts vs Nifty 500market median 0.0% · five sessions −5.2% (−5.0 pts vs Nifty 500) · volume 0.6× usual · delivery −5.0 pts against usual · The announcement
- 3 Aug 2026Board or managers changeddown 0.41%−1.9 pts vs Nifty 500market median 0.0% · five sessions −3.9% (−4.9 pts vs Nifty 500) · volume 0.3× usual · delivery 0.0 pts against usual · The announcement
- 29 Jul 2026Resultsdown 1.33%−2.4 pts vs Nifty 500market median −0.7% · five sessions −5.0% (−7.4 pts vs Nifty 500) · volume 1.2× usual · delivery −8.6 pts against usual · The announcement
- 27 Jul 2026Board or managers changeddown 0.30%−1.3 pts vs Nifty 500market median 0.0% · five sessions −5.7% (−8.1 pts vs Nifty 500) · volume 0.4× usual · delivery −2.0 pts against usual · The announcement
- 30 Apr 2026Resultsup 13.03%+13.8 pts vs Nifty 500market median −0.7% · five sessions +22.7% (+21.2 pts vs Nifty 500) · volume 110.8× usual · delivery −50.2 pts against usual · The announcement
- 28 Jan 2026Resultsdown 6.65%−7.8 pts vs Nifty 500market median −0.7% · five sessions −5.9% (−5.9 pts vs Nifty 500) · volume 31.4× usual · delivery −32.1 pts against usual · The announcement
- 20 Oct 2025Resultsup 5.37%+4.9 pts vs Nifty 500market median −0.7% · five sessions +4.5% (+3.5 pts vs Nifty 500) · volume 18.8× usual · delivery +16.3 pts against usual · The announcement
- 20 Oct 2025Board or managers changedup 5.37%+4.9 pts vs Nifty 500market median 0.0% · five sessions +4.5% (+3.5 pts vs Nifty 500) · volume 18.8× usual · delivery +16.3 pts against usual · The announcement
- 28 Jul 2025Resultsdown 9.90%−9.2 pts vs Nifty 500market median −0.7% · five sessions −5.7% (−4.2 pts vs Nifty 500) · volume 4.3× usual · delivery −5.1 pts against usual · The announcement
- 28 Jul 2025Board or managers changeddown 9.90%−9.2 pts vs Nifty 500market median 0.0% · five sessions −5.7% (−4.2 pts vs Nifty 500) · volume 4.3× usual · delivery −5.1 pts against usual · The announcement
20 earlier announcements
- 29 Apr 2025Dividendup 2.77%+2.7 pts vs Nifty 500market median 0.0% · five sessions −5.2% (−4.5 pts vs Nifty 500) · volume 31.3× usual · delivery −27.9 pts against usual · The announcement
- 29 Apr 2025Resultsup 2.77%+2.7 pts vs Nifty 500market median −0.7% · five sessions −5.2% (−4.5 pts vs Nifty 500) · volume 31.3× usual · delivery −27.9 pts against usual · The announcement
- 8 Apr 2025Board or managers changedup 2.25%+0.4 pts vs Nifty 500market median 0.0% · five sessions +9.6% (+3.1 pts vs Nifty 500) · volume 0.8× usual · delivery −7.8 pts against usual · The announcement
- 27 Jan 2025Resultsup 9.02%+10.9 pts vs Nifty 500market median −0.7% · five sessions +17.1% (+15.9 pts vs Nifty 500) · volume 21.9× usual · delivery −36.4 pts against usual · The announcement
- 8 Nov 2024Resultsdown 6.23%−5.5 pts vs Nifty 500market median −0.7% · five sessions −18.7% (−15.0 pts vs Nifty 500) · volume 2.3× usual · delivery −5.0 pts against usual · The announcement
- 14 Aug 2024Board or managers changedup 2.77%+2.9 pts vs Nifty 500market median 0.0% · five sessions +4.3% (+1.4 pts vs Nifty 500) · volume 0.4× usual · delivery −10.9 pts against usual · The announcement
- 22 Jul 2024Resultsup 3.03%+2.6 pts vs Nifty 500market median −0.7% · five sessions +7.0% (+5.1 pts vs Nifty 500) · volume 9.5× usual · delivery −32.2 pts against usual · The announcement
- 9 May 2024Board or managers changedup 0.31%+2.0 pts vs Nifty 500market median 0.0% · five sessions +0.5% (+0.3 pts vs Nifty 500) · volume 1.0× usual · delivery −13.2 pts against usual · The announcement
- 2 May 2024Dividenddown 2.45%−2.9 pts vs Nifty 500market median 0.0% · five sessions −6.5% (−5.1 pts vs Nifty 500) · volume 5.3× usual · delivery +5.9 pts against usual · The announcement
- 6 Mar 2024Credit ratingup 3.18%+3.2 pts vs Nifty 500market median 0.0% · five sessions −5.7% (−2.1 pts vs Nifty 500) · volume 12.2× usual · delivery −43.8 pts against usual · The announcement
- 2 Feb 2024Resultsup 2.59%+1.9 pts vs Nifty 500market median −0.7% · five sessions +1.9% (+0.8 pts vs Nifty 500) · volume 2.7× usual · delivery −0.1 pts against usual · The announcement
- 31 Jul 2023Resultsup 3.63%+3.0 pts vs Nifty 500market median −0.7% · five sessions +5.5% (+5.8 pts vs Nifty 500) · volume 3.2× usual · delivery −6.2 pts against usual · The announcement
- 2 May 2023Dividenddown 4.82%−5.4 pts vs Nifty 500market median 0.0% · five sessions −6.9% (−8.3 pts vs Nifty 500) · volume 2.1× usual · delivery −9.7 pts against usual · The announcement
- 24 Apr 2023Dividendup 1.29%+0.7 pts vs Nifty 500market median 0.0% · five sessions +4.8% (+2.2 pts vs Nifty 500) · volume 0.7× usual · delivery −2.1 pts against usual · The announcement
- 2 May 2022Resultsdown 9.65%−9.3 pts vs Nifty 500market median −0.7% · five sessions −14.7% (−9.3 pts vs Nifty 500) · volume 4.3× usual · delivery +0.4 pts against usual · The announcement
- 2 May 2022Dividenddown 9.65%−9.3 pts vs Nifty 500market median 0.0% · five sessions −14.7% (−9.3 pts vs Nifty 500) · volume 4.3× usual · delivery +0.4 pts against usual · The announcement
- 27 Jan 2022Resultsdown 4.85%−3.8 pts vs Nifty 500market median −0.7% · five sessions −5.3% (−8.4 pts vs Nifty 500) · volume 1.3× usual · delivery −10.4 pts against usual · The announcement
- 1 Nov 2021Resultsup 13.90%+12.5 pts vs Nifty 500market median −0.7% · five sessions +9.5% (+6.6 pts vs Nifty 500) · volume 6.9× usual · delivery −15.2 pts against usual · The announcement
- 29 Jul 2021Resultsup 4.93%+4.5 pts vs Nifty 500market median −0.7% · five sessions +4.3% (+1.4 pts vs Nifty 500) · volume 9.1× usual · delivery −24.0 pts against usual · The announcement
- 3 May 2021Resultsdown 3.59%−3.8 pts vs Nifty 500market median −0.7% · five sessions −7.1% (−8.7 pts vs Nifty 500) · volume 0.9× usual · delivery −3.8 pts against usual · The announcement
RPG Life Sciences results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.